Santa Barbara-based Quintessent raises $40M in Series A
By Jorge Mercado / Monday, August 24th, 2026 / Latest news, middle, Santa Barbara County, Subscriber content, Technology, Top Stories, Top Story / Comments Off on Santa Barbara-based Quintessent raises $40M in Series A
Santa Barbara-based Quintessent, a semiconductor company that specializes in resilient and low-cost AI datacenter optical interconnect products, announced it has raised $40 million in an oversubscribed Series A investment round. Announced Aug. 24, Quintessent also announced the start of a customer sampling of its single-chip quantum dot-based DWDM comb laser — a new class of light Read More →
Women and wealth panel
By Staff Report / Sunday, August 23rd, 2026 / Central Coast, Columns, Economy, Latest news, Subscriber content, Top Stories, Top Story, Tri-County Economy / Comments Off on Women and wealth panel
For our August Women & Wealth panel, we asked our experts to weigh in on longevity planning and some of the non-financial considerations for retirement. Our Q&A was conducted via email in mid-August and the responses were lightly edited. Our panelists are: Austyn Shepherd Abbas, senior vice president and private client manager at Bank of America, Nicole Read More →

New Santa Barbara CEO excited to start top role
By Henry Dubroff / Friday, August 21st, 2026 / Latest news, Santa Barbara County, Subscriber content, Top Stories, Top Story / Comments Off on New Santa Barbara CEO excited to start top role
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Limoneira’s Windfall Farms nets $15M in all-cash sale
By Jorge Mercado / Monday, August 17th, 2026 / Agribusiness, Central Coast, Latest news, Subscriber content, Top Stories, Top Story, Tri-County Economy / Comments Off on Limoneira’s Windfall Farms nets $15M in all-cash sale
Santa Paula-based Limoneira announced the successful sale of its 724-acre vineyard property in Paso Robles, Windfall Farms, for $15 million in an all-cash deal with a private buyer. Announced Aug. 17, the sale follows a competitive public auction conducted by Concierge Auctions in cooperation with Sotheby’s International Realty, which started on Aug. 15. The transaction Read More →
Latigo’s successful IPO boosts Conejo Valley
By Jorge Mercado / Thursday, August 13th, 2026 / East Ventura County, Latest news, Subscriber content, Technology, Top Stories, Top Story, Tri-County Public Companies / Comments Off on Latigo’s successful IPO boosts Conejo Valley
The success of the Conejo Valley’s burgeoning biotechnology and life sciences scene was boosted after Thousand Oaks-based Latigo Biotherapeutics, in its Aug. 6 initial public offering, raised $345.6 million, exceeding its initial fundraising expectations. Originally, the company expected to offer 16 million shares between $16 and $18 apiece. In the final offering, Latigo sold 19.2 million shares at Read More →

26 companies represent the region on 2026 Inc. 5000 list
By Jorge Mercado / Wednesday, August 12th, 2026 / Central Coast, Latest news, Subscriber content, Technology, Top Stories, Top Story / Comments Off on 26 companies represent the region on 2026 Inc. 5000 list
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Latigo Bio IPO exceeds expectations
By Jorge Mercado / Friday, August 7th, 2026 / East Ventura County, Latest news, Technology, Top Stories, Top Story, Tri-County Public Companies / Comments Off on Latigo Bio IPO exceeds expectations
Thousand Oaks-based Latigo Biotherapuetics became the latest Central Coast-based company to hit the stock market and did so in style with a better than expected raise. Latigo, a biotech company developing non-opioid pain medicines, blew away expectations after going public on Aug. 6, raising $345.6 million in its upsized listing. Originally, the company expected to offer Read More →







